샘플 요청 목록

 카트 문의
시장보고서
상품코드
1774695

세계의 고양이 백신 시장

Cat Vaccines
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 466 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

고양이 백신 세계 시장은 2030년까지 17억 달러에 달할 전망

2024년에 11억 달러로 추정되는 고양이 백신 세계 시장은 분석 기간인 2024-2030년에 CAGR 8.1%로 성장하여 2030년에는 17억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 개량/약독화 생백신은 CAGR 9.2%를 기록하며 분석 기간 종료시에는 9억 6,510만 달러에 달할 것으로 예측됩니다. 불활화 백신 분야 성장률은 분석 기간 동안 CAGR 7.2%로 추정됩니다.

미국 시장은 추정 2억 9,080만 달러, 중국은 CAGR 12.8%로 성장 예측

미국의 고양이 백신 시장은 2024년에 2억 9,080만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 12.8%로 2030년까지 3억 6,970만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 4.0%와 7.8%로 예측됩니다. 유럽에서는 독일이 CAGR 5.4%로 성장할 것으로 예측됩니다.

세계의 고양이 백신 시장 - 주요 동향과 촉진요인 정리

고양이 백신에 대한 수요가 증가하는 이유는 무엇일까?

고양이 건강에 대한 인식이 높아지고 예방적 수의학이 확산되면서 전 세계적으로 고양이 백신에 대한 수요가 크게 증가하고 있습니다. 반려동물 사육률이 지속적으로 증가하면서 고양이 백혈병 바이러스(FeLV), 광견병, 고양이 칼리시 바이러스(FCV)와 같은 치명적인 질병으로부터 반려동물을 보호하기 위해 정기적인 백신 접종을 우선순위에 두는 보호자들이 늘고 있습니다. 반려동물 산업이 예방적 건강관리로 전환함에 따라 백신은 고양이 웰빙 계획의 필수 요소로 자리 잡았습니다. 또한, 정부 및 비정부기구는 특히 길고양이 개체수가 많은 지역에서 백신 접종 프로그램을 적극적으로 추진하고 있습니다. 인수공통전염병 예방에 대한 관심이 높아짐에 따라 규제 당국은 백신에 대한 접근성과 규정 준수를 보장하기 위한 가이드라인을 강화하고 있습니다. 이러한 노력은 전염성 고양이 질병의 발생을 예방하기 위해 핵심 예방접종과 비핵심 예방접종의 중요성을 강조하는 수의사협회에 의해 더욱 뒷받침되고 있습니다.

수의학의 발전은 고양이 백신에 어떤 영향을 미쳤을까?

수의학 분야에서는 백신 개발이 크게 발전하여 고양이에게 더 효과적이고 오래 지속되는 예방접종 옵션이 점점 더 많아지고 있습니다. 재조합 DNA 기술과 벡터 기반 백신은 고양이 백신의 효능과 안전성을 향상시키고 부작용의 위험을 줄이며 더 오래 지속되는 면역력을 제공합니다. 이러한 기술 혁신으로 여러 바이러스 균주 및 박테리아에 대한 예방 효과를 향상시킨 새로운 백신이 개발되고 있습니다. 또한, 비강 백신과 비보조제 백신의 도입으로 주사 부위 반응에 대한 우려가 해소되어 고양이에게 보다 편안한 백신 접종이 가능해졌습니다. 면역학의 발전은 또한 고양이의 나이, 건강 상태 및 생활 방식에 맞는 백신 접종을 가능하게하여 개별화 된 백신 접종 일정의 길을 열었습니다. 수의학 생명공학의 지속적인 연구로 백신 제제 및 전달 방법의 지속적인 개선으로 시장은 혜택을 받을 것으로 예상됩니다.

고양이 백신의 채택을 촉진하는 시장 동향은 무엇인가?

고양이 백신 시장을 형성하는 주요 트렌드 중 하나는 혼합 백신에 대한 선호도가 높아지고 있다는 것입니다. 혼합 백신은 한 번의 접종으로 여러 질병에 대한 면역력을 제공함으로써 종합적인 보호 효과를 보장하고 동물병원을 여러 번 방문해야 하는 번거로움을 줄일 수 있습니다. 이러한 백신에 대한 수요는 고양이에게 편리하고 비용 효율적인 예방접종 옵션을 원하는 보호자들 사이에서 특히 높은 편입니다. 또 다른 새로운 트렌드는 반려동물 보험사나 동물병원에서 제공하는 예방 수의학 패키지의 확산입니다. 이러한 패키지에는 정기적인 백신 접종, 진단 검사, 기생충 제거가 포함되는 경우가 많아 백신 접종률을 높이는 데 도움이 됩니다. 또한, 반려동물 헬스케어 분야에서 E-Commerce가 확산되면서 동물용 백신이 더욱 친숙해졌고, 온라인 플랫폼은 택배 및 정기 구매 기반 백신 서비스를 쉽게 이용할 수 있게 되었습니다.

고양이 백신 시장의 주요 성장 촉진요인은 무엇인가?

고양이 백신 시장의 성장은 반려동물 사육 증가, 백신 기술 발전, 고양이 전염병의 유병률 증가 등 여러 가지 요인에 의해 이루어지고 있습니다. 또한, 특히 신흥 시장에서 동물 의료 인프라의 확대는 양질의 백신 접종 서비스에 대한 접근성을 개선하여 시장 성장에 기여하고 있습니다. 또한, 광견병 예방접종 및 기타 고양이 전염병 예방 프로그램에 대한 규제 의무화가 백신 보급을 촉진하고 있습니다. 반려동물의 복지와 책임감 있는 사육에 대한 관심이 높아짐에 따라 정기적인 백신 접종 준수율이 높아지고 있습니다. 또한, 고양이 전용 질병에 대한 연구 이니셔티브가 확대됨에 따라 향후 몇 년 동안 더 효과적인 새로운 백신이 도입될 것으로 예상됩니다. 수의학이 계속 발전하는 가운데 고양이 백신은 고양이 건강 관리에 필수적인 요소로 남아 전 세계 길고양이와 길고양이 집단의 행복을 보장할 것입니다.

부문

백신 유형(개량/약독화 생백신, 불활화 백신, 기타 백신 유형), 질환(고양이 호흡기질환, 고양이 백혈병 질환, 고양이 범백혈구 감소증 질환, 고양이 광견병 질환, 기타 질환), 투여 경로(주사제 투여 경로, 경비 투여 경로), 면역 기간(1년 면역 기간, 3년 면역 기간, 기타 면역 기간)

조사 대상 기업 사례

  • Bioveta, a. s.
  • Boehringer Ingelheim International GmbH
  • Durvet Inc.
  • Elanco Animal Health Incorporated
  • Greencross Vets
  • Indian Immunologicals Ltd.
  • Mars, Inc.
  • Medivet
  • Merck Animal Health
  • Petco Animal Supplies, Inc.
  • The Vets Holding Inc.
  • VIRBAC Animal Health India Private Ltd.
  • Virbac SA
  • Zoetis, Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.31

Global Cat Vaccines Market to Reach US$1.7 Billion by 2030

The global market for Cat Vaccines estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Modified / Attenuated Live Vaccines, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$965.1 Million by the end of the analysis period. Growth in the Inactivated Vaccines segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$290.8 Million While China is Forecast to Grow at 12.8% CAGR

The Cat Vaccines market in the U.S. is estimated at US$290.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$369.7 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Cat Vaccines Market - Key Trends & Drivers Summarized

Why Is the Demand for Cat Vaccines Increasing?

The growing awareness of feline health and the increasing adoption of preventive veterinary care have significantly boosted the demand for cat vaccines worldwide. As pet ownership continues to rise, more cat owners are prioritizing regular vaccinations to protect their pets from life-threatening diseases such as feline leukemia virus (FeLV), rabies, and feline calicivirus (FCV). The shift toward preventative healthcare in the pet industry has made vaccines an essential component of feline wellness plans. Additionally, governmental and non-governmental organizations are actively promoting vaccination programs, particularly in regions with high stray cat populations. With an increased focus on zoonotic disease prevention, regulatory authorities are strengthening guidelines to ensure widespread vaccine accessibility and compliance. These efforts are further supported by veterinary associations emphasizing the importance of core and non-core vaccinations to prevent outbreaks of contagious feline diseases.

How Are Advancements in Veterinary Medicine Impacting Cat Vaccines?

The field of veterinary medicine is witnessing significant advancements in vaccine development, leading to more effective and long-lasting immunization options for cats. Recombinant DNA technology and vector-based vaccines are enhancing the efficacy and safety of feline vaccines, reducing the risk of adverse reactions while providing longer immunity. These innovations have led to the development of novel vaccines that offer improved protection against multiple strains of viruses and bacteria. Moreover, the introduction of intranasal and non-adjuvanted vaccines is addressing concerns over injection-site reactions, making vaccinations more comfortable for cats. Advances in immunology have also paved the way for personalized vaccination schedules, ensuring that feline vaccinations are tailored based on age, health status, and lifestyle factors. With ongoing research in veterinary biotechnology, the market is expected to benefit from continuous improvements in vaccine formulations and delivery methods.

What Market Trends Are Driving the Adoption of Cat Vaccines?

One of the major trends shaping the cat vaccine market is the increasing preference for combination vaccines. These formulations provide immunity against multiple diseases in a single dose, reducing the need for multiple veterinary visits while ensuring comprehensive protection. The demand for these vaccines is particularly high among pet owners who seek convenient and cost-effective immunization options for their cats. Another emerging trend is the rising adoption of preventive veterinary care packages offered by pet insurance providers and veterinary clinics. These packages often include routine vaccinations, diagnostic screenings, and parasite control measures, encouraging higher vaccine uptake. Additionally, the growing penetration of e-commerce in the pet healthcare sector is making veterinary vaccines more accessible, with online platforms facilitating home delivery and subscription-based vaccine services.

What Are the Key Growth Drivers in the Cat Vaccines Market?

The growth in the Cat Vaccines market is driven by several factors, including increasing pet ownership, advancements in vaccine technology, and the rising prevalence of feline infectious diseases. The expansion of veterinary healthcare infrastructure, particularly in emerging markets, is also contributing to market growth by improving access to high-quality vaccination services. Additionally, regulatory mandates for rabies vaccination and other feline disease prevention programs are fueling vaccine adoption. The growing focus on pet welfare and responsible pet ownership is leading to higher compliance rates for routine vaccinations. Furthermore, the expansion of research initiatives targeting feline-specific diseases is expected to introduce new and more effective vaccines in the coming years. As veterinary medicine continues to evolve, cat vaccines will remain a crucial component of feline healthcare, ensuring the well-being of domestic and stray cat populations globally.

SCOPE OF STUDY:

The report analyzes the Cat Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Vaccine Type (Modified/Attenuated Live Vaccines, Inactivated Vaccines, Other Vaccine Types); Disease (Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases, Other Diseases); Route of Administration (Injectables Route of Administration, Intranasal Route of Administration); Duration of Immunity (1 Year Duration of Immunity, 3 Years Duration of Immunity, Other Durations of Immunities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Bioveta, a. s.
  • Boehringer Ingelheim International GmbH
  • Durvet Inc.
  • Elanco Animal Health Incorporated
  • Greencross Vets
  • Indian Immunologicals Ltd.
  • Mars, Inc.
  • Medivet
  • Merck Animal Health
  • Petco Animal Supplies, Inc.
  • The Vets Holding Inc.
  • VIRBAC Animal Health India Private Ltd.
  • Virbac SA
  • Zoetis, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cat Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Preventive Veterinary Care Drives Demand for Core and Non-Core Cat Vaccines
    • Technological Advancements in Vaccine Formulations Strengthen Efficacy and Safety Profiles
    • Growth in Companion Animal Healthcare Spending Expands Addressable Market for Cat Immunization
    • Regulatory Approvals and Vaccination Guidelines Propel Standardized Vaccine Adoption
    • Partnerships Between Veterinary Clinics and Pharma Companies Enhance Distribution and Accessibility
    • Emergence of Combination Vaccines Reduces Clinic Visits and Boosts Market Penetration
    • Epidemiological Trends and Outbreaks Throw Spotlight on the Importance of Routine Vaccination
    • Increased Adoption of Indoor and Outdoor Cats Drives Market Demand for Broad-Spectrum Vaccines
    • Expansion of Mobile Veterinary Services and Clinics Sustains Vaccination Outreach in Remote Areas
    • Digital Health Records and Pet Health Apps Drive Compliance with Vaccination Schedules
    • Public-Private Initiatives for Animal Health Awareness Strengthen Market for Preventive Care
    • Innovation in Needle-Free and Oral Vaccine Delivery Enhances Compliance and Reduces Stress
    • Globalization of Veterinary Pharma Markets Expands Access to Advanced Immunization Protocols
    • Growth in Feline Adoption Rates from Shelters Boosts Initial Vaccine Uptake
    • Challenges in Vaccine Storage and Cold Chain Management Create Demand for Thermostable Formulations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cat Vaccines Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cat Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Modified / Attenuated Live Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Modified / Attenuated Live Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Modified / Attenuated Live Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Vaccine Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Intranasal Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Intranasal Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Intranasal Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Injectables Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Injectables Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Injectables Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for 1 Year Duration of Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for 1 Year Duration of Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for 1 Year Duration of Immunity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for 3 Years Duration of Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for 3 Years Duration of Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for 3 Years Duration of Immunity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Durations of Immunities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Durations of Immunities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Durations of Immunities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Feline Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Feline Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Feline Respiratory Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Feline Leukemia Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Feline Leukemia Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Feline Leukemia Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Feline Panleukopenia Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Feline Panleukopenia Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Feline Panleukopenia Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Feline Rabies Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Feline Rabies Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Feline Rabies Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • JAPAN
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • CHINA
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • EUROPE
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Cat Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • FRANCE
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • GERMANY
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Spain 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Russia 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Cat Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Australia 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • INDIA
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 218: India Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: India 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: South Korea 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Cat Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Argentina 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Brazil 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Mexico 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Cat Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Cat Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Iran 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Israel 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: UAE 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030
  • AFRICA
    • Cat Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Cat Vaccines by Vaccine Type - Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Cat Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Modified / Attenuated Live Vaccines, Inactivated Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Cat Vaccines by Route Of Administration - Intranasal Route of Administration and Injectables Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Cat Vaccines by Route Of Administration - Percentage Breakdown of Value Sales for Intranasal Route of Administration and Injectables Route of Administration for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Cat Vaccines by Duration of Immunity - 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Cat Vaccines by Duration of Immunity - Percentage Breakdown of Value Sales for 1 Year Duration of Immunity, 3 Years Duration of Immunity and Other Durations of Immunities for the Years 2015, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Cat Vaccines by Disease - Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 403: Africa 15-Year Perspective for Cat Vaccines by Disease - Percentage Breakdown of Value Sales for Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases and Other Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제